Journal of Shanghai Jiao Tong University (Medical Science) ›› 2024, Vol. 44 ›› Issue (5): 635-640.doi: 10.3969/j.issn.1674-8115.2024.05.012
• Review • Previous Articles
CHEN Xiaochang(), ZHANG Chen(
)
Received:
2023-10-23
Accepted:
2024-02-27
Online:
2024-05-28
Published:
2024-05-28
Contact:
ZHANG Chen
E-mail:chenxiaochang1998@163.com;zhangchen645@163.com
Supported by:
CLC Number:
CHEN Xiaochang, ZHANG Chen. Progress in non-pharmacological interventions for weight gain in schizophrenia[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(5): 635-640.
Add to citation manager EndNote|Ris|BibTeX
URL: https://xuebao.shsmu.edu.cn/EN/10.3969/j.issn.1674-8115.2024.05.012
1 | OWEN M J, SAWA A, MORTENSEN P B. Schizophrenia[J]. Lancet, 2016, 388(10039): 86-97. |
2 | TIAN Y, LIU D Y, WANG D M, et al. Obesity in Chinese patients with chronic schizophrenia: prevalence, clinical correlates and relationship with cognitive deficits[J]. Schizophr Res, 2020, 215: 270-276. |
3 | AFZAL M, SIDDIQI N, AHMAD B, et al. Prevalence of overweight and obesity in people with severe mental illness: systematic review and meta-analysis[J]. Front Endocrinol, 2021, 12: 769309. |
4 | FIRTH J, SIDDIQI N, KOYANAGI A, et al. The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness[J]. Lancet Psychiatry, 2019, 6(8): 675-712. |
5 | MAZEREEL V, DETRAUX J, VANCAMPFORT D, et al. Impact of psychotropic medication effects on obesity and the metabolic syndrome in people with serious mental illness[J]. Front Endocrinol, 2020, 11: 573479. |
6 | NIELSEN R E, BANNER J, JENSEN S E. Cardiovascular disease in patients with severe mental illness[J]. Nat Rev Cardiol, 2021, 18(2): 136-145. |
7 | SISKIND D, GALLAGHER E, WINCKEL K, et al. Does switching antipsychotics ameliorate weight gain in patients with severe mental illness? A systematic review and meta-analysis[J]. Schizophr Bull, 2021, 47(4): 948-958. |
8 | VANCAMPFORT D, FIRTH J, CORRELL C U, et al. The impact of pharmacological and non-pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta-review of meta-analyses of randomized controlled trials[J]. World Psychiatry, 2019, 18(1): 53-66. |
9 | AGARWAL S M, STOGIOS N, AHSAN Z A, et al. Pharmacological interventions for prevention of weight gain in people with schizophrenia[J]. Cochrane Database Syst Rev, 2022, 10(10): CD013337. |
10 | LEE K, ABRAHAM S, CLEAVER R. A systematic review of licensed weight-loss medications in treating antipsychotic-induced weight gain and obesity in schizophrenia and psychosis[J]. Gen Hosp Psychiatry, 2022, 78: 58-67. |
11 | SKOLNIK N S, RYAN D H. Pathophysiology, epidemiology, and assessment of obesity in adults[J]. J Fam Pract, 2014, 63(7 Suppl): S3-S10. |
12 | MONEM R G, OKUSAGA O O. Repetitive transcranial magnetic stimulation: a potential treatment for obesity in patients with schizophrenia[J]. Behav Sci, 2021, 11(6): 86. |
13 | DIPASQUALE S, PARIANTE C M, DAZZAN P, et al. The dietary pattern of patients with schizophrenia: a systematic review[J]. J Psychiatr Res, 2013, 47(2): 197-207. |
14 | MÖTTELI S, PROVAZNIKOVA B, VETTER S, et al. Examining nutrition knowledge, skills, and eating behaviours in people with severe mental illness: a cross-sectional comparison among psychiatric inpatients, outpatients, and healthy adults[J]. Nutrients, 2023, 15(9): 2136. |
15 | CORRELL C U, HØJLUND M, GRAHAM C, et al. Weight gain and metabolic changes in patients with first-episode psychosis or early-phase schizophrenia treated with olanzapine: a meta-analysis[J]. Int J Neuropsychopharmacol, 2023, 26(7): 451-464. |
16 | BARTON B B, SEGGER F, FISCHER K, et al. Update on weight-gain caused by antipsychotics: a systematic review and meta-analysis[J]. Expert Opin Drug Saf, 2020, 19(3): 295-314. |
17 | WU H, SIAFIS S, HAMZA T, et al. Antipsychotic-induced weight gain: dose-response meta-analysis of randomized controlled trials[J]. Schizophr Bull, 2022, 48(3): 643-654. |
18 | PILLINGER T, MCCUTCHEON R A, VANO L, et al. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis[J]. Lancet Psychiatry, 2020, 7(1): 64-77. |
19 | JEON S W, KIM Y K. Unresolved issues for utilization of atypical antipsychotics in schizophrenia: antipsychotic polypharmacy and metabolic syndrome[J]. Int J Mol Sci, 2017, 18(10): 2174. |
20 | CUNNINGHAM J I, EYERMAN D J, TODTENKOPF M S, et al. Samidorphan mitigates olanzapine-induced weight gain and metabolic dysfunction in rats and non-human primates[J]. J Psychopharmacol, 2019, 33(10): 1303-1316. |
21 | MANU P, DIMA L, SHULMAN M, et al. Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management[J]. Acta Psychiatr Scand, 2015, 132(2): 97-108. |
22 | FALKAI P, SCHMITT A, ROSENBEIGER C P, et al. Aerobic exercise in severe mental illness: requirements from the perspective of sports medicine[J]. Eur Arch Psychiatry Clin Neurosci, 2022, 272(4): 643-677. |
23 | FERNÁNDEZ-ABASCAL B, SUÁREZ-PINILLA P, COBO-CORRALES C, et al. In- and outpatient lifestyle interventions on diet and exercise and their effect on physical and psychological health: a systematic review and meta-analysis of randomised controlled trials in patients with schizophrenia spectrum disorders and first episode of psychosis[J]. Neurosci Biobehav Rev, 2021, 125: 535-568. |
24 | ROMAIN A J, FANKAM C, KARELIS A D, et al. Effects of high intensity interval training among overweight individuals with psychotic disorders: a randomized controlled trial[J]. Schizophr Res, 2019, 210: 278-286. |
25 | SISMAN F N, BÜBER B, TAŞ F, et al. Randomized controlled trial for the effects of an exercise program for functional remission and weight control in schizophrenia: a community mental health study[J]. Issues Ment Health Nurs, 2022, 43(7): 603-612. |
26 | ZHANG L, ZHU M W, LIU X Q, et al. Calorie-restricted diet mitigates weight gain and metabolic abnormalities in obese women with schizophrenia: a randomized controlled trial[J]. Front Nutr, 2023, 10: 1038070. |
27 | DAUMIT G L, DICKERSON F B, WANG N Y, et al. A behavioral weight-loss intervention in persons with serious mental illness[J]. N Engl J Med, 2013, 368(17): 1594-1602. |
28 | CABASSA L J, STEFANCIC A, LEWIS-FERNÁNDEZ R, et al. Main outcomes of a peer-led healthy lifestyle intervention for people with serious mental illness in supportive housing[J]. Psychiatr Serv, 2021, 72(5): 555-562. |
29 | RAFN B S, ANDERSEN M F, SØRENSEN V, et al. Value of gym-based group exercise versus usual care for young adults receiving antipsychotic medication: study protocol for the multicenter randomized controlled Vega trial[J]. BMC Psychiatry, 2023, 23(1): 634. |
30 | LUCIANO M, SAMPOGNA G, AMORE M, et al. How to improve the physical health of people with severe mental illness? A multicentric randomized controlled trial on the efficacy of a lifestyle group intervention[J]. Eur Psychiatry, 2021, 64(1): e72. |
31 | MIDTGAARD J, SCHNOR H, BJERRE E D, et al. Exercise training complementary to specialised early intervention in patients with first-episode psychosis: a feasibility randomised trial[J]. Pilot Feasibility Stud, 2021, 7(1): 162. |
32 | TORTORELLA A. We should improve personalization of management in patients with a diagnosis of schizophrenia[J]. J Clin Med, 2021, 11(1): 184. |
33 | ARTERBURN D E, TELEM D A, KUSHNER R F, et al. Benefits and risks of bariatric surgery in adults: a review[J]. JAMA, 2020, 324(9): 879-887. |
34 | SUMITHRAN P, ROBERTS L, CATERSON I D, et al. Incidence of adverse mental health outcomes after sleeve gastrectomy compared with gastric bypass and restrictive bariatric procedures: a retrospective cohort study[J]. Obesity, 2023, 31(7): 1913-1923. |
35 | WARD H B, YUDKOFF B L, FROMSON J A. Lurasidone malabsorption following bariatric surgery: a case report[J]. J Psychiatr Pract, 2019, 25(4): 313-317. |
36 | ARCHID R, ARCHID N, MEILE T, et al. Patients with schizophrenia do not demonstrate worse outcome after sleeve gastrectomy: a short-term cohort study[J]. Obes Surg, 2019, 29(2): 506-510. |
37 | BRITO M E, SAMPAIO I M, FERREIRA A C, et al. Patients with schizophrenia undergoing gastric bypass surgery: a case series study[J]. Obes Surg, 2020, 30(10): 3813-3821. |
38 | LAGERROS Y T, BRANDT L, SUNDBOM M, et al. Risk of delayed discharge and reoperation of gastric bypass patients with psychiatric comorbidity: a nationwide cohort study[J]. Obes Surg, 2020, 30(7): 2511-2518. |
39 | SAMUELS J, CARMICHAEL H, HAZEL K, et al. Chronic psychiatric diagnoses increase emergency department utilization following bariatric surgery[J]. Surg Endosc, 2023, 37(3): 2215-2223. |
40 | KOUIDRAT Y, AMAD A, STUBBS B, et al. Surgical management of obesity among people with schizophrenia and bipolar disorder: a systematic review of outcomes and recommendations for future research[J]. Obes Surg, 2017, 27(7): 1889-1895. |
41 | LI Z J, ZHANG L B, CHEN Y X, et al. Advancements and challenges in neuromodulation technology: interdisciplinary opportunities and collaborative endeavors[J]. Sci Bull, 2023, 68(18): 1978-1982. |
42 | LEFAUCHEUR J P, ALEMAN A, BAEKEN C, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): an update (2014‒2018)[J]. Clin Neurophysiol, 2020, 131(2): 474-528. |
43 | KIM S H, CHUNG J H, KIM T H, et al. The effects of repetitive transcranial magnetic stimulation on body weight and food consumption in obese adults: a randomized controlled study[J]. Brain Stimul, 2019, 12(6): 1556-1564. |
44 | KIM S H, CHUNG J H, KIM T H, et al. The effects of repetitive transcranial magnetic stimulation on eating behaviors and body weight in obesity: a randomized controlled study[J]. Brain Stimul, 2018, 11(3): 528-535. |
45 | SU X R, WANG X, PAN X L, et al. Effect of repetitive transcranial magnetic stimulation in inducing weight loss in patients with chronic schizophrenia: a randomized, double-blind controlled 4-week study[J]. Curr Neuropharmacol, 2023, 21(2): 417-423. |
46 | DEVOTO F, FERRULLI A, ZAPPAROLI L, et al. Repetitive deep TMS for the reduction of body weight: bimodal effect on the functional brain connectivity in “diabesity”[J]. Nutr Metab Cardiovasc Dis, 2021, 31(6): 1860-1870. |
47 | FERRULLI A, DRAGO L, GANDINI S, et al. Deep transcranial magnetic stimulation affects gut microbiota composition in obesity: results of randomized clinical trial[J]. Int J Mol Sci, 2021, 22(9): 4692. |
48 | WHITING D M, TOMYCZ N D, BAILES J, et al. Lateral hypothalamic area deep brain stimulation for refractory obesity: a pilot study with preliminary data on safety, body weight, and energy metabolism[J]. J Neurosurg, 2013, 119(1): 56-63. |
49 | GLUCK M E, ALONSO-ALONSO M, PIAGGI P, et al. Neuromodulation targeted to the prefrontal cortex induces changes in energy intake and weight loss in obesity[J]. Obesity, 2015, 23(11): 2149-2156. |
50 | GRUNDEIS F, BRAND C, KUMAR S, et al. Non-invasive prefrontal/frontal brain stimulation is not effective in modulating food reappraisal abilities or calorie consumption in obese females[J]. Front Neurosci, 2017, 11: 334. |
[1] | XU Xiaojun, YE Minjie, WANG Yuchen, WANG Wenxia, QIAN Sheng, YE Dandi, PAN Lele, HU Xin, YIN Xiaoli, LI Meihua, LING Guangyao. A comparative study of prepulse inhibition in children with first episode schizophrenia and normal children [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(5): 606-610. |
[2] | FU Lirong, ZHANG Chen. Advances in the role of circular RNA in schizophrenia [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(11): 1445-1449. |
[3] | SHEN Hui, WU Yuejuan, ZHU Huijuan, XU Chuchen, ZHANG Li, FAN Qing. Analysis of therapeutic effect of mindfulness-based intervention on inpatients with chronic schizophrenia [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(12): 1693-1698. |
[4] | Ruping LU, Hui GAO, Linna JIANG, Xiaoya CHEN, Hong PENG, Hui SHEN, Qing FAN. Effect of psychomotor therapy on negative symptoms and cognitive function of patients with stable schizophrenia [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2022, 42(1): 77-81. |
[5] | Meng-ting SHEN, Xuan-hong ZHANG, Zhen-ying QIAN, Hui LI, Jian-hua SHENG, Ji-jun WANG, Ying-ying TANG. Comparison of mismatch negativity in patients with schizophrenia and depression [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(8): 1041-1045. |
[6] | Hong-yan XUAN, Li-hua WANG, Hua-fang LI. Review of the factors influencing bone metabolism in schizophrenia [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(7): 972-976. |
[7] | Bing-fu SONG, Bin-bin Ding, Xiao-li ZHANG, Li-yun YAO. Observation of therapeutic efficacy of metformin on glucose dysregulation and dyslipidaemia induced by quetiapine in patients with schizophrenia [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(6): 776-780. |
[8] | Guo-qin HU, Cheng-qing YANG, Qin-yu LÜ, Jing ZHAO, Ming-huan ZHU, Zheng-hui YI, Xin-hai DAI. Effects of computerized cognitive correction therapy on cognitive function of schizophrenia [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(5): 622-627. |
[9] | Yue-hua TU, Xiao-jin WANG, Bing-shun WANG. Effects of individualized nutritional standard meal intervention on the prevention of gestational diabetes in overweight and obese pregnant women [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(3): 360-365. |
[10] | Rui LI, Duan ZENG, Shen HE, Yi-feng SHEN, Hua-fang LI. Association study of HRAS proto-oncogene single nucleotide polymorphism with schizophrenia and therapeutic response to atypical antipsychotics [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(12): 1613-1617. |
[11] | Nuo-shi QIAN, Wu HONG, Chun-bo LI. Progress of transcranial direct current stimulation in the treatment of children and adolescents psychiatric disorders [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(10): 1366-1370. |
[12] | Hong YANG, Xin-xin HUANG, Chao LIU, Qing-song LIANG, Hua YANG, Jian-biao ZHANG, Jian XU, Ying-yi WANG, Hai-su WU, Qin-yu LÜ, Zheng-hui YI. Association study of synaptotagmin 2 gene polymorphisms with schizophrenia in Chinese Han population [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(1): 16-22. |
[13] | Guo-qin HU, Qin-yu LÜ, Jing ZHAO, Ming-huan ZHU, Shun-ying YU, Zheng-hui YI, Jian CHEN. Association study of non-coding variant of NOS1AP gene with schizophrenia [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(1): 29-34. |
[14] | YU Ling-fang1, FANG Xin-yu2, CHEN Yan1, WANG Dan-dan1, WANG Ye-wei1, WU Ze-nan1, LIU Rui-mei1, ZHANG Chen1. Analysis of the feature and influencing factors of anhedonia in schizophrenia [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(9): 1207-1212. |
[15] | ZHU Tian-yuan1, SHEN Meng-ting1, XU Li-hua1, ZHANG Tian-hong1, ZHANG Jian-ye2#, WANG Ji-jun1, TANG Ying-ying1#. Prediction of functional connectivity of fronto-limbic network in the outcome of subjects with clinical high-risk for psychosis [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(9): 1222-1228. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||